14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.83 $2.67 Wednesday, 24th Apr 2024 CGEN stock ended at $1.91. This is 3.54% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.47% from a day low at $1.90 to a day high of $1.99.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Oct 24, 2023 $0.678 $0.750 $0.678 $0.744 79 820
Oct 23, 2023 $0.675 $0.724 $0.675 $0.699 166 864
Oct 20, 2023 $0.751 $0.751 $0.700 $0.721 131 373
Oct 19, 2023 $0.782 $0.782 $0.718 $0.740 166 090
Oct 18, 2023 $0.84 $0.84 $0.760 $0.784 107 328
Oct 17, 2023 $0.84 $0.85 $0.80 $0.84 51 967
Oct 16, 2023 $0.83 $0.85 $0.80 $0.81 77 234
Oct 13, 2023 $0.790 $0.85 $0.760 $0.84 85 495
Oct 12, 2023 $0.81 $0.82 $0.780 $0.80 136 670
Oct 11, 2023 $0.87 $0.87 $0.780 $0.82 115 378
Oct 10, 2023 $0.82 $0.87 $0.81 $0.87 86 746
Oct 09, 2023 $0.81 $0.82 $0.750 $0.81 252 092
Oct 06, 2023 $0.87 $0.88 $0.82 $0.88 94 664
Oct 05, 2023 $0.85 $0.90 $0.83 $0.89 137 495
Oct 04, 2023 $0.90 $0.91 $0.80 $0.84 273 515
Oct 03, 2023 $0.93 $0.96 $0.88 $0.92 86 003
Oct 02, 2023 $0.93 $0.99 $0.93 $0.96 165 936
Sep 29, 2023 $0.88 $0.93 $0.87 $0.93 64 279
Sep 28, 2023 $0.93 $0.93 $0.85 $0.88 243 427
Sep 27, 2023 $0.96 $0.97 $0.80 $0.93 288 687
Sep 26, 2023 $0.99 $1.00 $0.93 $0.96 141 178
Sep 25, 2023 $0.96 $1.00 $0.96 $1.00 104 031
Sep 22, 2023 $1.01 $1.02 $0.96 $0.98 196 200
Sep 21, 2023 $1.05 $1.05 $0.93 $0.98 245 452
Sep 20, 2023 $1.04 $1.07 $1.02 $1.02 83 491
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT